Adenoviral-Based COVID-19 Vaccines May Up Short-Term CV Risk

TUESDAY, Aug. 23, 2022 -- Adenoviral-based COVID-19 vaccines may be associated with increased incidence of myocardial infarction and pulmonary embolism among people aged younger than 75 years, according to a study published online Aug. 23 in the...